Benzinga | Nov 18, 2021 11:56AM EST

SVB Leerink Maintains Market Perform on Agios Pharmaceuticals, Lowers Price Target to $42

SVB Leerink analyst Andrew Berens maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Market Perform and lowers the price target from $50 to $42.